comparemela.com

Supriya Lifesciences Q3 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Supriya Lifesciences Q3 Results: Net profit triples to Rs 30 crore

Revenues rose 33% YoY to Rs 140 crore in Q3FY24. Earnings before interest, taxes, depreciation and amortisation (EBITDA) for Q3FY24 almost tripled to reach Rs. 41.49 crore, with an EBITDA margin of 29.6% in Q3FY24, as opposed to 13.4%, an improvement of 1620 basis points.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.